These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 879096)

  • 21. [Significance of HBsAg in screening donors].
    Wang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Dec; 10(6):363-5. PubMed ID: 2624939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative evaluation of 5 third-generation methods for the detection of HBsAg].
    Dentico P; Baldi L; Trotta F; Buongiorno R; Pastore G; Schiraldi O
    Quad Sclavo Diagn; 1982 Sep; 18(3):361-7. PubMed ID: 7184049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of HBsAg in blood donors. A comparative study using radioimmunoassay, enzymeimmunoassay, reverse passive haemagglutination and latex tests.
    Seidl S; Trautmann L
    Rev Fr Transfus Immunohematol; 1981 Jun; 24(3):319-35. PubMed ID: 7025162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sandwich enzymoimmunoassay of hepatitis B surface antigen (HBsAg).
    Adachi H; Fukuda T; Funahashi S; Kurahori T; Ishikawa E
    Vox Sang; 1978; 35(4):219-23. PubMed ID: 358585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on the reliability of the confirmatory testing of reversed passive hemagglutination technic for the detection of HBs antigen].
    Ogata M; Honta S; Abe K
    Rinsho Byori; 1984 Nov; 32(11):1184-93. PubMed ID: 6394819
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju].
    Seo JH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):304-14. PubMed ID: 14695697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of HBsAg carrier rate in acute viral hepatitis and high risk individuals using RPHA and ELISA.
    Korgaonkar A; Verenkar MP; Savio R; Pinto MJ; Singh I
    Indian J Pathol Microbiol; 1996 Oct; 39(4):277-80. PubMed ID: 9009478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two techniques (RPHA and latex agglutination) for use as a screening tool for HBsAg.
    Ranga S; Pandey J; Talib VH
    Indian J Pathol Microbiol; 1994 Oct; 37(4):375-80. PubMed ID: 7868169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of methods of detection of hepatitis 'B' surface antigen (HBsAg).
    Parab VV; Talawadekar NN; Kale VV; Kamat SA
    J Postgrad Med; 1989 Apr; 35(2):83-5. PubMed ID: 2621667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Positive false reaction of HBsAg (by RPHA) in patients with schistosomiasis and its mechanism].
    Gui X
    Zhonghua Yi Xue Za Zhi; 1986 Nov; 66(11):680-2. PubMed ID: 3102014
    [No Abstract]   [Full Text] [Related]  

  • 32. [The evaluation of counter-immunoelectrophoresis and passive haemagglutination tests for HB2Ag (author's transl)].
    Kaynar V
    Mikrobiyol Bul; 1980 Apr; 14(2):121-6. PubMed ID: 7464580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen.
    Wolters G; Kuijpers L; Kacaki J; Schuurs A
    J Clin Pathol; 1976 Oct; 29(10):873-9. PubMed ID: 789402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis-associated markers in the American Red Cross volunteer blood donor population. ii. Distribution of level of HBsAg reactivity by radioimmunoassay and occurrence of nonspecific reactivity.
    Nath N; Fang CT; Berberian H; Bastiaans MJ; Dodd RY; Sandler SG; Barker LF
    Vox Sang; 1980 Aug; 39(2):73-8. PubMed ID: 7281597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation of methods for detecting HBsAg in sera].
    Semenova NP; Prokudina EN; Bocharova NG; Shalunova NV; Zhdanov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):12-4. PubMed ID: 3727875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative evaluation of three techniques of passive haemoagglutination for the determination of HBsAg (author's transl)].
    Aceti A; Vullo V; Ferone U; Delia S
    Quad Sclavo Diagn; 1978 Dec; 14(4):451-7. PubMed ID: 757620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of enhanced sensitivity in detecting HBsAg by Biotin-Avidin ELISA.
    Teng XC; Chia KM; Zeng LP; Ma JF
    Ann Acad Med Singap; 1986 Apr; 15(2):141-4. PubMed ID: 3752890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and comparison of two methods to detect hepatitis B antigen. Counterelectrophoresis (CEP) and reversed passive latex-agglutination (RPLA) technic in relationship to radioimmunoassay.
    Carvajal C; Di Bella J; Stincer M
    Am J Clin Pathol; 1976 Apr; 65(4):547-9. PubMed ID: 1266815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of hepatitis B surface antigen in potentially contaminated human plasma and plasma fractions.
    Harris RB; Semar M; Johnson AJ
    J Lab Clin Med; 1977 Dec; 90(6):1107-14. PubMed ID: 336817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved economics of HBsAg screening with commercial radioimmunoassay reagents.
    Hopkins R; Ross S; Jordan T; Watt AD
    J Clin Pathol; 1980 Jan; 33(1):19-23. PubMed ID: 6987272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.